Pharming Group (OTCMKTS:PHGUF - Get Free Report) is expected to announce its earnings results on Thursday, March 13th. Analysts expect the company to announce earnings of $0.01 per share and revenue of $76.67 million for the quarter.
Pharming Group Price Performance
PHGUF remained flat at $0.90 on Friday. The company has a market cap of $606.85 million, a P/E ratio of -45.22 and a beta of 0.91. The firm has a fifty day simple moving average of $0.92 and a 200-day simple moving average of $0.84. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.76 and a current ratio of 3.53. Pharming Group has a 1 year low of $0.75 and a 1 year high of $1.20.
Pharming Group Company Profile
(
Get Free Report)
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.
See Also
Before you consider Pharming Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pharming Group wasn't on the list.
While Pharming Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
